Wednesday 27 January 2016

Global Blood Components, Testing and Collection Market Spurred by Sudden Increases in New Infections

With consumers insisting on zero-risk blood supply, large investments are being put into development of pathogen reduction solutions.
Viral inactivation technologies for blood constituents will stimulate the next phase of development in the blood banking systems and plasma products market.
— Anasuya Vemuri
HYDERABAD, TELANGANA, INDIA, January 27, 2016 /EINPresswire.com/ -- RI Technologies' market research report on Blood – Components, Testing & Collection gives an insight into different areas including Blood Products, Blood Banking Devices (Such as Equipment involved in Collecting, Processing and Storing Blood and Blood Components), Blood Testing and Other (Such as Artificial Blood, Cord Blood and Recombinant Factors). Blood Products include Cellular Blood Components, Whole Blood and Plasma Derived Products (Immunoglobulins, Coagulation factors, Alpha-1 proteinase inhibitors, Albumins, Fibrin and Anti-Coagulants). Blood Testing includes Immunoassays, NAT and Other. The report provides an in depth analysis of each of the type and product areas by their respective categories. The study includes estimates and projections (2005 - 2020) for the total global Blood Research and Products market and also key regional markets that include North America, Europe, Japan, Asia-Pacific and Rest of World. 

This study is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in --
* Gauging Competitive Intelligence
* Identifying Key Growth Areas and Opportunities
* Understanding Geographic Relevance to Product
* Knowing Regional Market Sizes and Growth Opportunities and Restraints
* Keeping Tab on Emerging Technologies
* Tapping New Markets

Demand for blood products is set to rise in developed as well as developing countries due to aging population that needs sophisticated testings and intricate operations as well as rapid advancement and ready availability of advanced technologies. Hemoglobin-based oxygen carriers (HBOCs) and PFC-based products also may provide significant growth to the market. Even though people are now alert to the different infections, the industry is yet to overcome difficulties such as security, and the accessibility to good quality blood. This has led to very strict safety measurements being taken for both the donors as well as the blood banks which have to be adhered to before any transfusion is carried out. The risk of diseases spread through transfusions has decreased due to conduction of thorough testing and screening techniques and also with the assistance from latest technologies. Current conversion rates from plasma-derived to recombinant factor products are increasing the standard factor product cost. Collecting blood manually continues to be the most productive technique for collecting blood and the systems that are used in these procedures are extremely important to the blood banking industry.

Blood banks now readily await a safe technology that will combine with their processing systems and decrease the danger of transfusion-related infections to almost nil. The success of the market is ascertained by the capacity to provide cost-effective technologies with a wide kill range, strong safety profile and the effortlessness in the application. The provision to persuade the buyer decision making processes combined with first-mover advantage will be significant in achieving a competitive edge. The market will observe a strong operation towards combining device production knowledge and biopharmaceutical technology, as companies work towards producing safer blood collection techniques and blood replacements.

To order this market research report on Blood – Components, Testing & Collection, please contact us at contactus@researchimpact.com. You may also explore custom research services on Blood – Components, Testing & Collection with RI Technologies. 


About RI Technologies

Research Impact Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.
Anasuya Vemuri
Research Impact Technologies
+91 9676994272

Wednesday 30 December 2015

Unnatural Amino Acids - Increasing Applications in Pharmaceuticals

RI Technologies' market research study on Unnatural Amino Acids - market is driven by derivatives that find large applications in pharmaceuticals.
Optically clean unnatural amino acids are becoming more and more significant as pharmaceutically active compounds.
— Anasuya Vemuri
HYDERABAD, TELANGANA, INDIA, December 30, 2015 /EINPresswire.com/ -- RI Technologies' market researchreport on Unnatural Amino Acids gives a market insight into the different types of Unnatural Amino Acids (β-Amino Acids, β-Amino Acid Derivatives, Cyclic Amino Acids & Derivatives, D-Amino Acids, D-Amino Acid Derivatives, DL-Amino Acids, DL-Amino Acid Derivatives, L-Amino Acid Derivatives and Other ) and their application areas such as R&D, Pharmaceutical, Food & Feed, Agrochemicals and Other applications.
The study includes estimates and projections for the global Unnatural Amino Acids by type and applications. Regional Analysis is covered separately for North America (United States and Canada); Europe (UK, Germany, Switzerland, Italy, The Netherlands, and Rest of Europe; Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific); and Rest of World.

Business profiles of 57 major companies are discussed in the report. The report serves as a guide to global Unnatural Amino Acids industry covering more than1000 companies that are engaged in Unnatural Amino Acids R&D, synthesis, discovery, testing and supply of derivatives, products and services. Information related to industrial activity, corporate developments, research trends, product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.

Research - As Good as the Methodology is!

Development of selective peptide receptor ligands with orally administered drug properties has progressed rapidly in the past decade. Non-natural amino acids are accepted major tool to prepare peptide ligand mimetics with superior biological activity and proteolytic resistance. Non-natural amino acids have applications as pharmacologically active products, molecular scaffolds, conformational constraints and building blocks. They embody an almost countless array of different structural elements to develop new therapeutic drugs. In the field of pharmaceuticals, unnatural amino acids are found to have a very important role to play. Chiral amines also have an industrial significance and importance in the fine chemical arena and this is because of their use as resolving agents, catalysts for asymmetric synthesis, and chiral bases.

About 18% of the leading drugs and agrochemicals include amino acids in their synthesis. Unnatural amino acids can make proteins 30 times more effective in treating cancer. For example, L-Homophenylalanine is an unnatural amino acid and is an effective drug for the therapy of hypertension and congestive heart diseases. Diagnostic / Therapeutic medicine are the important application area of unnatural amino acids.

Owing to the growing importance of unnatural amino acids as pharmaceutical intermediates, a range of methods are being developed for their enantiomerically pure preparation. Regularly employed processes consist of resolutions by diastereomeric crystallization, enzymatic resolution of derivatives, partition by simulated moving bed (SMB) and chiral chromatography. These methods are adopted to separate racemic mixtures but the highest hypothetical yield is expected to be around 50%.

For non-proteinogenic L-amino acids such as L-nor-valine, L-nor-leucine, L-2-amino-5-[1-3], dioxolan-2-yl-pentanoic acid, L-tert-leucine and others; the preferred method for their synthesis is enzymecatalyzed reductive aminations.
Optically clean unnatural amino acids are becoming more and more significant as pharmaceutically active compounds. Chiral directing auxiliaries, and chiral synthons are widely being used in organic synthesis. The use of D-amino acids in the production of semi-synthetic antibiotics is increasing very fast and is being widely preferred. The drugs - ampicillin and amoxicillin - are produced using D-phenylglycine and p-hydroxy-Dphenylglycine respectively. These drugs are found to be broad-based and more stable compared to enzymatic degradation than naturally occurring (benzyl) penicillin. The production quantity of p-Hydroxy-D-phenylglycine ranges in several kilotons per year.

For more information please contact us - contactus@researchimpact.com

About RI Technologies

Research Impact Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.


Research Impact Technologies
Tel +91 9676994272 
Email: contactus@researchimpact.com
Anasuya Vemuri
Research Impact Technologies
+91 9676994272
email us here

Friday 4 December 2015

Biologics - Shaping the Future of Drug Discovery and Development

Biologics for rheumatic diseases, which focus on molecules concerned with the techniques connected with immune systems, offer a good option to the current treatment procedures for autoimmune diseases.
Research Impact Technologies' latest update on Biologics market provides an exclusive insight into this field of complex medications. Global Biologics market is projected to grow at 9.33% compounded annually from 2005 through 2020. Blood and blood products are the major product area with tremendous potential and growth. Automated blood collection and processing systems as well as prior-screening capabilities of latest assays are expected to enhance quantity and quality of blood. Since the last decade, the therapeutic market for monoclonal antibodies has grown exponentially. Bevacizumab, Trastuzumab, Adalimumab, Infliximab and Rituximab are the top five therapeutic antibodies available. About 40% of the best selling biopharmaceuticals are therapeutic monoclonal antibodies. Development of vaccines has proved to be crucial and effective in the pharmaceutical industry. Growing human and animal populations and advancement of science and technology are the driving factors behind the global vaccines market. High prevalence of diabetes, treatment and diagnosis rates, device penetration and changes in price are driving the human insulin market. Biologics market holds tremendous potential and promise. 

Since the approval of insulin as the first recombinant therapeutic protein, biologic therapies in drug development have gained immense significance. Biologics have delivered life changing results. Many unmet medical needs are being addressed for several disease areas using traditional replacement proteins to more recent, highly engineered antibodies, oligonucleotides, fusion proteins, and gene constructs. 

The market study analyzes the Biologics market by product type, application area and by disease area. Product types include Monoclonal Antibodies, Blood & Blood Products, Vaccines, Insulin and Other, while application areas are for both human and animal consumption. The disease areas covered include autoimmune diseases, oncology, infectious Diseases, Diabetes and other. The report serves as a guide to Biologics market, covering more than 800 companies that are engaged in Biologics products and services. Major Contract Research Organizations, Research Institutes and Universities serving the Biologics market are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to Biologic products is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, and Rest of World with more than 150 exclusive graphically represented exhibits.

This report may help Drug Developing Companies, Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information


To order this market research report on Biologics, please contact us atcontactus@researchimpact.com. You may also explore custom research services on Biologics with RI Technologies. 


About RI Technologies

Research Impact Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.


contactus@researchimpact.com
Anasuya Vemuri
Research Impact Technologies
+91 9676994272

Wednesday 4 November 2015

Identify Market Opportunities, Know Competition, Get Actionable Information

Research Impact Technologies' life science reports are unique in their market analysis and business forecasts, providing invaluable market and company insights.
Research Impact believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data.
— Anasuya Vemuri
HYDERABAD, TELANGANA, INDIA, November 4, 2015 /EINPresswire.com/ -- Research Impact Technologies has announced discounts on its portfolio of Biotech, Medical & Life Science Market Research Reports. The strategic market information tables, graphically represented, greatly aid research needs and help in forecasting, and gearing up to the future, armed with qualitative research. This will significantly reduce risks of new product development and will give a global vision and perspective to company products. Several data tables, charts, and graphs complement the text. Exclusive market numbers are provided for several hard to find niche markets.

Research Impact believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information that will help companies probe into and support critical business decisions.


Diligent market research reports featuring several market data dynamics may help companies to -
o Identify Market Opportunities
o Review and Analyze Global and Regional Markets
o Gauge Market Potential
o Identify Competition
o Acquire Meaningful Guidelines for Strategic Planning
o Gear up for Market Entry


Niche Biotechnology, Medical, Life Science Related Studies

ADME/Tox Technologies
High Throughput Screening
Biomarkers
Metabolomics
Stem Cells - Types, Technologies & Therapeutics
RNAi
Angiogenesis Modulators
Apoptosis
Chiral Chemicals
Biological Implants
Bionanotechnology
Biochips
hERG Screening
DNA Sequencing
Intravenous Solutions
Amino Acids
Glucosamine
Biotechnology in India
Prions
Bio Imaging
Veterinary Vaccines
Biopesticides
GPCR - Drug Targets
Stem Cell Research in Cardiology
Tissue Sealants
Feed Nucleotides
Unnatural Amino Acids
Liposomes
Blood - Components, Testing and Collection
Polylactic Acid
Lactic Acid
D-Amino Acids
Polyethylene Glycol Dimethyl Ether (PEG DME)
Biosensors
Biodegradable Stents
Circulating Tumor Cells (CTC) Technologies
Bioinformatics
Ethanol
Biologics
Security Technologies in Biotechnology
Polyols

For any specific data cut or any specific market analysis, Research Impact's Custom Research Services are designed to support companies through the most important business decisions. Stay Focused! Save Time! Grow your Revenues!

For strategic market research and exclusive custom research, Research Impact Technologies can be contacted at 
contactus@researchimpact.com 

About Research Impact

Research Impact Technologies is a premier source of market research on several life science related sectors. The company emphasizes on factual insights and forecasts with maximum global coverage. Research Impact is constantly monitoring the biotechnology & Healthcare industry, tracking market trends, and forecasting industry based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging technologies in areas of discovery, design and development. The company's product portfolio includes extensive market insight reports, company insight reports, country reports, and exclusive data tables. Customized to customer needs and requirements, custom research reports are extremely focused, with great importance given to deadlines and budget. RI Technologies strives to provide diligent market research reports that empower customers with enlightening critical business information.
Anasuya Vemuri
Research Impact Technologies
+91 9676994272

Saturday 3 October 2015

FEED NUCLEOTIDES - GLOBAL MARKET RESEARCH REPORT

FEED NUCLEOTIDES - GLOBAL MARKET RESEARCH REPORT - BY APPLICATION, BY SOURCE, BY ANIMAL CATEGORY, BY TYPE

Premier Source of Biotech, Medical & Life Science Market Research Reports
Feed Nucleotides demand in animals is accelerated due to stress and rapid growth and the necessity may be heightened during the immediate post weaning period.
Of immunostimulants (glucan, chitin, levamisole and lipopolysaccharides), Nucleotides (important constituent of enzymes and cofactors such as ATP, NAD and FAD) hold the widest attention globally.
— Anasuya Vemuri
HYDERABAD, TELANGANA, INDIA, October 3, 2015 /EINPresswire.com/ -- RI Technologies' Global Market Research Report on Feed Nucleotides provides market analytics by application, by source, by type and by animal categories. The market is divided by Application into Immune Stimulators, Dietary Supplements and Other; by Source into Yeast/Yeast Extracts, Single Celled Organisms and Other; and by Animal Categories into Swine, Poultry, Aquaculture and Other. The market is also divided by Type into IMP (Inosine Monophosphate), GMP (Guanosine Monophosphate) and Other (AMP+CMP+UMP). The study also provides global market analysis for Feed Additives and Nucleotides, both in value and volume terms.

Nucleotides are needed for the regular immune system function, cell repair after injury or disease, and also to prevent disease. Nucleotides are also essential to overcome the negative effects of hormones released during stress and to build up immune system. Global Feed Nucleotides market is projected to reach over US$200 million by 2020. CJ CheilJedang Bio business is a global leader in the market for feed amino acids and fermented nucleotides for food. Nucleotides are used commercially as feed additives for improving animal growth or as immunity enhancers. Protein rich feeds generally contain Nucleotides, particularly inosine 5'-monophosphate (IMP). Feed ingredients containing cellular elements are potential dietary sources of nucleotides (nucleoproteins). Good sources of nucleoproteins include organ meals, poultry and seafood. Ingredients such as Single-cell proteins, bakers and brewers yeast, and yeast extract have high concentrations of nucleotides.

Disease outbreak is a major problem for all animal species. Antibiotics are generally used widely to prevent disease. However, prolonged use of antibiotics has resulted in the development of resistant strains of pathogens that can resist the antibiotics. Alternatively, immunostimulants (such as glucan, chitin, levamisole and lipopolysaccharides) are being developed to enhance the immunity systems of animals. Of these immunostimulants, nucleotides (important constituent of enzymes and cofactors such as ATP, NAD and FAD) hold the widest attention globally. Several nucleotide programs have effectively demonstrated highly significant effects on health and performance parameters. Over the last few years, significant investments have been made in R&D and developing feed nucleotide products. The usage of dietary nucleotides, because of several beneficial features, is rapidly increasing and many feed additive companies are including nucleotides in their products and/or are entering into business collaborations with already existing nucleotide producing companies.

This report on Feed Nucleotides may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential
Identify Competition
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry

Learn more about Feed Nucleotides report here. For custom research services on Feed Nucleotides market, please contact us.

About RI Technologies

RI Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.

Friday 11 September 2015

Circulating Tumor Cells (CTC) - Set to Become a Regular Screening Test for Cancers

Just as common as colonoscopies and mammograms, Circulating Tumor Cells (CTC) Screening may become a regular affair for many types of cancers.
http://www.einpresswire.com/article/285181960/circulating-tumor-cells-ctc-set-to-become-a-regular-screening-test-for-cancers

HYDERABAD, TELANGANA, INDIA, September 8, 2015 /EINPresswire.com/ -- Since cancer is a disease of genetic mutations, the future treatments will be based on assessing how the mutation leads to cancer. Cells within a single cancer tumor may possess different mutations, and hence several targeted therapies are imperative for treating even a single type of cancer. The challenge is to develop techniques for preventing cancer and identifying cancer at its earliest stages (when cancer is more treatable). Since the average life expectancy of the world’s population is increasing, the chances of developing cancer also increase. CTC Screening is slated to be an effective mechanism for identifying cancer at its earliest stages and thereby reducing cancer deaths. 

RI Technologies' market research report on Circulating Tumor Cells (CTC) Technologies gives a market insight into technologies and services used for cancer detection. The market is analyzed by Cancer type into Prostate, Breast and Other; and by Function into Prognostics, Diagnostics and Therapy Management. The report serves as a guide to CTC markets, covering more than 150 companies that are engaged in CTC studies/screening, products and services. Major Contract Research Organizations, Research Institutes and Universities serving the CTC market are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to CTC Technologies is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, and Asia-Pacific. 

The biggest technical challenge is CTC detection despite the continued development of many new technologies. The key need is for a technology that will detect the real metastasis-initiating CTC which in turn will trigger distant metastases. This may be a combination of complementary technologies or even several technologies optimized for specific tumor types. CTC enrichment depends on the different properties of CTCs that distinguish them from the surrounding normal hematopoietic cells; physical properties; and biological properties. Most of the current technologies are still based on epithelial cell adhesion molecule (EpCAM) expression. New emerging technologies may try to capture EpCAM-negative CTCs.

Global CTC Technologies market is predicted to cross US$ 12 billion by the year 2020. The worldwide cancer incidence rate is growing alarmingly. As per statistics, the number of global cancer deaths is projected to increase about 45-50% (about 8 million deaths) from 2007 to 2030 (about 12 million deaths). This is due to increasing and aging populations worldwide. Cancer is the second largest cause of death in most developed countries after cardiovascular disease, and developing countries too are now showing the same pattern. Unless tobacco controls are strictly followed, lung cancer will continue to kill more people than any other cancer. Prostate, breast and colon cancers are more common in developed countries, while liver, cervical and stomach cancers are more common in developing countries. 


To order this market research report on CTC Technologies, please contact us at contactus@researchimpact.com. You may also explore customized research services on CTC Technologies with RI Technologies. 


About RI Technologies

RI Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.


contactus@researchimpact.com

www.researchimpact.com
RI Technologies
+91 9676994272

Thursday 20 August 2015

DNA Vaccines - Latest Breakthrough in the Field of Molecular Technology

Prevention of diseases by immunization saves money from wastage on post-disease therapeutic agents like antibiotics. The induced immunity alleviates the sufferings of animals from diseases. Immunization has saved countless number of animals worldwide from premature mortality. The products derived from vaccinated animals are safe and do not pose any health hazard to human consumers. Vaccination has not only prevented the occurrence of many diseases, but also has eradicated certain human and animal diseases totally.
The principle of vaccination was evolved more than two centuries ago. Since then, rapid progress has been achieved in the preparation of vaccines. The vaccine, when first injected, triggers the immune system of the recipient to produce antibodies against the infectious agent. This primary vaccination course for dogs and cats involves two or more administrations because of variations in the MDA levels encountered in individuals. Certain vaccines against diseases, as for example Leptospirosis, are given twice to produce sufficient titer of antibodies in the serum of the recipients. Booster doses of vaccination are given to maintain adequate level of serum antibodies.
RI Technologies' Veterinary Vaccines market research report covers the Types of Veterinary Vaccines and the different Species for which Vaccines are present in the market. The Types of Veterinary Vaccines covered include Live Attenuated, Inactivated, Recombinant and Other (Conjugate Vaccines, DNA Vaccines, Toxoids etc). The Species include Bovine, Porcine, Poultry, Canine & Feline, Ovine & Caprine and Other (Equine, Fish, Wild Animals etc.). The study includes estimates and projections for the total global Veterinary Vaccines market and also key regional markets that include Europe, North America, Asia-Pacific Latin America, Middle East and Rest of World. Estimates and projections are illustrated graphically.
Business profiles of 13 major companies are discussed in the report. The report serves as a guide to global Veterinary Vaccines industry, covering 365 companies that are engaged in the development and supply of Veterinary Vaccines.Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.
please contact us.
Anasuya Vemuri
+91 9676994272

Monday 17 August 2015

Bioimaging - A Prominent Advancement in the Field of Biomedical Research

Pharmaceutical industries make use of the imaging output obtained from simple microphotograph to sophisticated images obtained through MRI, CT, PET, X-ray, and sonography. Pharmocological researchers are focusing their attention on MRI and PET scans. The application of these imaging techniques is expected to boost productive drug research and help in the assessment of the suitability of a specific drug for treatment of human diseases. Among the imaging techniques, PET occupies the place of first choice in drug research. The researchers use radiopharmaceuticals labeled with positron emitting radionuclides. By measuring the annihilation radiation using a coincidence technique, pharmacokinetics of the drug used and its effect on metabolism can be evaluated. In drug discovery, it is important to evaluate the biological effect of the drug, its comparative efficacy, its binding affinity, and its accumulation in the target organ in effective concentration. Such valuable information could be gathered by means of using PET scan.
Bioimaging techniques are regarded as the most promising advancements in the field of present day healthcare and biomedical research. This is being recognized as one of the most comprehensive achievements, which has eased the working conditions of the physicians. In the present medical scenario majority of the diseases are being diagnosed and attended using biomedical imaging techniques. This technique requires a good amount of development to understand the basic functions of the organs in the living system. The main aim of the concept of bioimaging is to provide an effective understanding of the numerous available imaging modalities like X-ray, Commuted Tomography, Emission Tomography and Magnetic Resonance Imaging. This is done by relating the basic operating principles of these techniques with that of Imaging techniques.
RI Technologies' Global Market Research Report on Bioimaging focuses on the different types and modalities of bioimaging and their application in Research and Development and Diagnostics. The study provides global market analysis for bioimaging by Modalities including Ultrasound, CT, MRI, PET, SPECT and other modalities comprising X-Ray, TEM and OCT. The study includes estimations and predictions for the total global bioimaging market. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents and Research related to Bioimaging is also provided. A global perspective is presented in Bio Imaging Market size along with regional analysis covering North America, Europe, Asia-Pacific, Latin America, and Rest of World.
For more information on this report please contactus -   
Anasuya Vemuri
RI Technologies

Wednesday 12 August 2015

Prion diseases such as Bovine Spongiform Encephalopathies (BSE) and the variant Creutzfeldt-Jakob Disease (vCJD) pose considerable health risks to human beings.

Prions research studies are gaining importance. The neurodegenerative diseases in animals and humans caused by prions are fatal and are still incurable to date.

Prions are classified depending on the resistance that they offer to traditional inactivation practices like dry heat, boiling, irradiation, and chemical treatment. The prion infectivity observed in purified samples is reduced owing to repeated digestion with proteases. Similarly, the results obtained from boiling in sodium dodecyl sulfate and urea also indicate varying values. The other process, which has greatly influenced the inactivation procedure, is the denaturing process. The experiments carried out using organic solvents like phenol or chaotropic reagents have indicated that this process enables inactivation partially. In addition, the various traditional methods available did not help in achieving complete inactivation of prions.

http://www.einpresswire.com/article/280741782/prions-global-market-research-report-ri-technologies-update